Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Leishmanisis Outbreak Effects Thousands

By R&D Editors | October 15, 2010

KABUL, Afghanistan (AP) – An outbreak of a tropical disease caused by sand fly bites that leaves disfiguring skin sores has hit Afghanistan, with tens of thousands of people infected, health officials said.

Cutaneous leishmanisis is a parasitic disease transmitted by the female phlebotomine sand fly – an insect only 2-3 millimeters long that requires the blood of humans or animals so its eggs can develop. Treatable with medication and not life-threatening, cutaneous leishmanisis can leave severe scars on the bodies of victims.

The disease threatens 13 million people in Afghanistan, the World Health Organization said, and many impoverished Afghan victims can’t afford the medication to treat it.

In Kabul – described by the WHO as “the world capital of cutaneous leishmaniasis” – the number of cases jumped from an estimated 17,000 a year in the early 2000s to 65,000 in 2009, WHO said.

Most victims are women and children. WHO said women and children are more vulnerable because they mostly live indoors at night, where the sand flies prefer to bite, and are therefore more susceptible than men who are generally outside the home.

Peter Graaff, WHO representative to Afghanistan, told The Associated Press on Friday that the stigma and shame attached to the disfiguring disease results in underreporting, and the number of infected people is likely much higher.

“This number is likely to be the tip of the iceberg as cases are grossly underreported,” said Graaff.

An outbreak has occurred in a small village in western Herat province’s Kohsan district with 63 people infected since August, Graaff said.

The cause of the outbreak was unknown and a WHO team has been dispatched to investigate, he said.

The sand flies proliferate from June to September. They thrive in unsanitary conditions such as piles of garbage and debris, though bed nets offer protection from their bites. As the disfiguring sores grow larger, many suffer social stigmatization.

“The high cost of treatment makes it difficult to integrate anti-Leishmaniasis drugs,” said Dr. Suraya Dalil, acting minister of public health. “I urge donors to take this cause seriously, as it causes unnecessary suffering amongst a large number of Afghans.”

According to the WHO as many as 12 million people are infected worldwide with the disease, with about 1 million to 2 million new cases annually.

Date: October 15, 2010
Source: Associated Press

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE